GlassScriptPhysician profile
Sarah Ramsey Brown
NPI 1255910295
$635.57
in general payments reported to CMS, 2019-2025
19 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.36 · 2022: $118 · 2023: $100 · 2024: $171 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.24 | 2023-2025 | Xifaxan |
| Novo Nordisk INC | $78.96 | 2024-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $46.57 | 2022 | |
| Dexcom, INC. | $40.82 | 2024-2025 | Dexcom G6 Transmitter |
| Zimmer Biomet Holdings, INC. | $40.81 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $37.80 | 2024-2025 | |
| Convatec INC. | $31.16 | 2025 | |
| Csl Behring | $30.44 | 2022 | |
| Lilly USA, LLC | $25.88 | 2025 | Jardiance |
| Zimvie INC. | $24.93 | 2023 | |
| Glaxosmithkline, LLC. | $24.36 | 2021 | |
| Janssen Biotech, INC. | $21.48 | 2025 | Erleada |
| Pacira Pharmaceuticals Incorporated | $20.27 | 2025 | Iovera, Zilretta |
| Abbvie INC. | $19.36 | 2025 | |
| Pfizer INC. | $18.82 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.37 | 2024 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $17.07 | 2023 | Quviviq |
| Nevro Corp. | $15.25 | 2023 | Senza |
| Djo, LLC | $14.98 | 2023 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.